Platelet Ubiquitylation—It's Everywhere

Elizabeth E. Gardiner; Robert K. Andrews

doi:10.1055/s-0038-1676650

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2019; 119(01): 006-008
DOI: 10.1055/s-0038-1676650

Invited Editorial Focus

Georg Thieme Verlag KG Stuttgart · New York

Platelet Ubiquitylation—It's Everywhere

Authors

Elizabeth E. Gardiner

¹Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, Australian National University, Canberra, Australia
Robert K. Andrews

²Australian Centre for Blood Diseases, Monash University, Melbourne, Australia

Abstract

Full Text

References

References
1 Rüegg C, Tissot JD, Farmer P, Mariotti A. Omics meets hypothesis-driven research. Partnership for innovative discoveries in vascular biology and angiogenesis. Thromb Haemost 2008; 100 (05) 738-746
2 Cubedo J, Suades R, Padro T. , et al. Erythrocyte-heme proteins and STEMI: implications in prognosis. Thromb Haemost 2017; 117 (10) 1970-1980
3 Cubedo J, Blasco A, Padro T. , et al. Molecular signature of coronary stent thrombosis: oxidative stress and innate immunity cells. Thromb Haemost 2017; 117 (09) 1816-1827
4 Loroch S, Trabold K, Gambaryan S. , et al. Alterations of the platelet proteome in type I Glanzmann thrombasthenia caused by different homozygous delG frameshift mutations in ITGA2B. Thromb Haemost 2017; 117 (03) 556-569
5 Niki M, Nayak MK, Jin H. , et al. Dok-1 negatively regulates platelet integrin αIIbβ3 outside-in signalling and inhibits thrombosis in mice. Thromb Haemost 2016; 115 (05) 969-978
6 Solari FA, Mattheij NJ, Burkhart JM. , et al. Combined quantification of the global proteome, phospho-proteome, and proteolytic cleavage to characterize altered platelet functions in the human Scott syndrome. Mol Cell Proteomics 2016; 15 (10) 3154-3169
7 Watson SP, Bahou WF, Fitzgerald D, Ouwehand W, Rao AK, Leavitt AD. ; ISTH Platelet Physiology Subcommittee. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost 2005; 3 (09) 2098-2101
8 Senzel L, Gnatenko DV, Bahou WF. The platelet proteome. Curr Opin Hematol 2009; 16 (05) 329-333
9 Burkhart JM, Vaudel M, Gambaryan S. , et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012; 120 (15) e73-e82
10 Fong KP, Barry C, Tran AN. , et al. Deciphering the human platelet sheddome. Blood 2011; 117 (01) e15-e26
11 Unsworth AJ, Bombik I, Pinto-Fernandez A, McGouran JF, Konietzny R, Zahedi RP, Watson SP, Kessler BM, Pears CJ. Human platelet protein ubiquitylation and changes following GPVI activation. Thromb Haemost 2019; 119 (01) 104-116
12 Gardiner EE, Andrews RK. Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI. Transfus Med Rev 2014; 28 (02) 56-60
13 Deppermann C. Platelets and vascular integrity. Platelets 2018; 29 (06) 549-555
14 Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol 2018; 11 (01) 125
15 Arthur JF, Shen Y, Gardiner EE. , et al. TNF receptor-associated factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets. J Thromb Haemost 2011; 9 (01) 163-172
16 Arthur JF, Qiao J, Shen Y. , et al. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. J Thromb Haemost 2012; 10 (06) 1133-1141
17 Iyengar PV. Regulation of ubiquitin enzymes in the TGF-β pathway. Int J Mol Sci 2017; 18 (04) E877
18 Singh R, Karri D, Shen H. , et al. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. J Clin Invest 2018; 128 (07) 3129-3143